Pitcairn CO Evotec Se Transaction History
Pitcairn CO
- $1.24 Billion
- Q3 2025
A detailed history of Pitcairn CO transactions in Evotec Se stock. As of the latest transaction made, Pitcairn CO holds 161,769 shares of EVO stock, worth $488,542. This represents 0.05% of its overall portfolio holdings.
Number of Shares
161,769
Previous 261,181
38.06%
Holding current value
$488,542
Previous $1.1 Million
46.44%
% of portfolio
0.05%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding EVO
# of Institutions
37Shares Held
4.06MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.43MShares$4.32 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.2MShares$3.62 Million1.96% of portfolio
-
Morgan Stanley New York, NY315KShares$951,0340.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA300KShares$906,8360.0% of portfolio
-
Abc Arbitrage Sa Paris, I0132KShares$398,8120.05% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.07B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...